drugset / Trial / NCT01683747
Single Dose Enteral Tranexamic Acid in Critically Ill Patients
Phase 2
Terminated
4 enrolled
San Diego Veterans Healthcare System
Inflammagen/Leading Ventures · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The premise of this study is that enteral tranexamic acid will help to maintain small bowel integrity, which is often compromised by critical illness due to inadequate cardiovascular perfusion (i.e., shock), and that maintenance of small bowel integrity will decrease morbidity in critically ill patients.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | — | Other |